Noxilizer Expands Access to Commercial-Scale Nitrogen Dioxide Terminal Sterilization Capacity with $30 Million in Growth Capital Led by NewVale Capital
Investment accelerates global adoption of Noxilizer’s terminal sterilization alternative that is validated, safe, scalable and sustainable for biopharmaceutical and medical device manufacturers HANOVER, Md., Sept. 10, 2025 /PRNewswire/ — Noxilizer, Inc. (“Noxilizer”), the leader in nitrogen dioxide-based terminal sterilization for…